In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...